How Do You Spell ANTIGLOBULIN AUGMENTED LYMPHOCYTOTOXICITY TEST?

Pronunciation: [ˌantɪɡlˈɒbjʊlˌɪn ɔːɡmˈɛntɪd lˌɪmfəsˌɪtətəksˈɪsɪti tˈɛst] (IPA)

The Antiglobulin Augmented Lymphocytotoxicity Test (AALT) is a medical test that measures the ability of a patient's immune system to target and destroy foreign cells. The word 'antiglobulin' is pronounced /æn.ti.gləˈbu.lɪn/, and refers to the antibodies used in the test. 'Augmented' is pronounced /ɔːɡˈmɛntɪd/, and means that the test is enhanced by a substance called complement. 'Lymphocytotoxicity', pronounced /lɪm.fəʊˌsaɪ.təʊˈtɒk.sɪˌsɪ.ti/, refers to the process by which lymphocytes are destroyed. The spelling of this term is complex, but accurate transcription using the International Phonetic Alphabet can help clarify its pronunciation.

ANTIGLOBULIN AUGMENTED LYMPHOCYTOTOXICITY TEST Meaning and Definition

1. The Antiglobulin Augmented Lymphocytotoxicity Test, also known as the antiglobulin complement-mediated lymphocytotoxicity test (ACMC), is a laboratory diagnostic procedure used to detect the presence of antibodies and complement factors on the surface of lymphocytes or other blood cells. The test is primarily employed in the field of immunology and is commonly used in the investigation of autoimmune diseases, blood transfusion reactions, and certain immune deficiencies.

   During the Antiglobulin Augmented Lymphocytotoxicity Test, patient's lymphocytes are mixed with antibodies and complement in a test tube. The antibodies specifically target antigens present on the surface of the lymphocytes. If the lymphocytes are coated with these specific antibodies, subsequent addition of antiglobulins enhances the reaction by promoting the formation of antibody-antigen-complement complexes. The addition of a dye or other marker allows for the visualization of these complexes and thus indicates the presence of antibodies and complement on the lymphocyte surface.

   The Antiglobulin Augmented Lymphocytotoxicity Test has been an important tool in diagnosing autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis, and systemic vasculitides. It has also been used to assess lymphocyte compatibility prior to blood transfusion, especially during the screening for potential adverse reactions. This test aids in determining the presence of antibodies that may cause immune destruction of transfused blood cells, leading to hemolysis or other complications. Due to its high sensitivity and versatility, the Antiglobulin Augmented Lymphocytotoxicity Test remains a valuable technique in immunology laboratories worldwide.

Common Misspellings for ANTIGLOBULIN AUGMENTED LYMPHOCYTOTOXICITY TEST

• zntiglobulin augmented lymphocytotoxicity test
• sntiglobulin augmented lymphocytotoxicity test
• wntiglobulin augmented lymphocytotoxicity test
• qntiglobulin augmented lymphocytotoxicity test
• abtiglobulin augmented lymphocytotoxicity test
• amtiglobulin augmented lymphocytotoxicity test
• ajtiglobulin augmented lymphocytotoxicity test
• ahtiglobulin augmented lymphocytotoxicity test
• anriglobulin augmented lymphocytotoxicity test
• anfiglobulin augmented lymphocytotoxicity test
• angiglobulin augmented lymphocytotoxicity test
• anyiglobulin augmented lymphocytotoxicity test
• an6iglobulin augmented lymphocytotoxicity test
• an5iglobulin augmented lymphocytotoxicity test
• antuglobulin augmented lymphocytotoxicity test
• antjglobulin augmented lymphocytotoxicity test
• antkglobulin augmented lymphocytotoxicity test
• antoglobulin augmented lymphocytotoxicity test
• ant9globulin augmented lymphocytotoxicity test
• ant8globulin augmented lymphocytotoxicity test